These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7117381)
1. Receptor interactions of imidazolines. Influence of ionization constant on the diffusion of clonidine and a series of structurally related imidazolidines into and out of the central nervous system. Ruffolo RR; Yaden EL; Ward JS Eur J Pharmacol; 1982 Jul; 81(3):367-75. PubMed ID: 7117381 [No Abstract] [Full Text] [Related]
2. Quantitative structure-activity relationships in centrally acting imidazolidines structurally related to clonidine. Timmermans PB; van Zwieten PA J Med Chem; 1977 Dec; 20(12):1636-44. PubMed ID: 201756 [TBL] [Abstract][Full Text] [Related]
3. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. I. Central hypotensive and peripheral hypertensive activities. de Jonge A; Timmermans PB; van Zwieten PA J Pharmacol Exp Ther; 1982 Sep; 222(3):705-11. PubMed ID: 6125586 [No Abstract] [Full Text] [Related]
4. Receptor interactions of imidazolines. XI. Alpha-adrenergic and antihypertensive effects of clonidine and its methylene-bridged analog, St 1913. Ruffolo RR; Yaden EL; Waddell JE; Ward JS Pharmacology; 1982; 25(4):187-201. PubMed ID: 6128747 [No Abstract] [Full Text] [Related]
5. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Armah BI; Hofferber E; Stenzel W Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of [3H]clonidine binding to rat brain alpha-adrenoceptors by imidazolidines. Correlation of binding potency and hypotensive activity. Bechtel WD; Mierau J; Timmermans PB Arzneimittelforschung; 1985; 35(1A):428-31. PubMed ID: 2985095 [TBL] [Abstract][Full Text] [Related]
7. Receptor interactions of imidazolines. IV. Structural requirements for alpha adrenergic receptor occupation and receptor activation by clonidine and a series of structural analogs in rat aorta. Ruffolo RR; Waddell JE; Yaden EL J Pharmacol Exp Ther; 1980 May; 213(2):267-72. PubMed ID: 6102600 [TBL] [Abstract][Full Text] [Related]
8. Lipophilicity and brain disposition of clonidine and structurally related imidazolidines. Timmermans PB; Brands A; van Zwieten PA Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):217-26. PubMed ID: 600309 [TBL] [Abstract][Full Text] [Related]
9. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats. Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761 [TBL] [Abstract][Full Text] [Related]
11. [Studies on the mechanism of action of clonidine after pretreatment with reserpine (author's transl)]. Tauberger G; Thoneick HU; Dülme HJ Arzneimittelforschung; 1978; 28(4):651-4. PubMed ID: 581942 [TBL] [Abstract][Full Text] [Related]
12. Clonidine and related analogues. Quantitative correlations. Rouot B; Leclerc G; Wermuth CG J Med Chem; 1976 Aug; 19(8):1049-54. PubMed ID: 9510 [TBL] [Abstract][Full Text] [Related]
13. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. II. Central and peripheral bradycardic activities. de Jonge A; Timmermans PB; van Zwieten PA J Pharmacol Exp Ther; 1982 Sep; 222(3):712-9. PubMed ID: 6125587 [No Abstract] [Full Text] [Related]
14. [Preliminary pharmacological evaluation of new imidazolidinone-2, ethylenediamine and imidazoline derivatives]. Jagiełło-Wójtowicz E; Zebrowska-Lupina I; Wielosz M; Stelmasiak M; Szurska G; Porowska A; Kleinrok Z Acta Pol Pharm; 1984; 41(4):495-504. PubMed ID: 6532135 [No Abstract] [Full Text] [Related]
15. The central action of clonidine and its antagonism. Katic F; Lavery H; Lowe RD Br J Pharmacol; 1972 Apr; 44(4):779-87. PubMed ID: 4339388 [TBL] [Abstract][Full Text] [Related]
16. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. Ernsberger P; Giuliano R; Willette RN; Reis DJ J Pharmacol Exp Ther; 1990 Apr; 253(1):408-18. PubMed ID: 2158551 [TBL] [Abstract][Full Text] [Related]
17. New 2-aryliminoimidazolidines. I. Synthesis and antihypertensive properties of 2-(2-phenoxyphenylimino)imidazolidines and related compounds. Matsuo M; Taniguchi K; Katsura Y; Kamitani T; Ueda I Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4409-21. PubMed ID: 4092269 [No Abstract] [Full Text] [Related]
18. The hypothermic effect of clonidine and other imidazolidines in relation to their ability to enter the central nervous system in mice. McLennan PL Eur J Pharmacol; 1981 Feb; 69(4):477-82. PubMed ID: 6265229 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the central and peripheral components for induction of postural hypotension by guanethidine, clonidine, dopamine2 receptor agonists and 5-hydroxytryptamine1A receptor agonists. Park KH; Long JP; Cannon JG J Pharmacol Exp Ther; 1991 Dec; 259(3):1221-30. PubMed ID: 1762069 [TBL] [Abstract][Full Text] [Related]
20. Central and peripheral alpha-adrenergic effects of some imidazolidines. Timmermans PB; Van Zwieten PA Eur J Pharmacol; 1977 Oct; 45(3):229-36. PubMed ID: 200437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]